Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA

Mycoplasma pneumoniae infections decreased in Ohio, USA, during the COVID-19 pandemic but reemerged in 2023; >2,000 cases were reported during September 2023­–September 2024. Of 995 M. pneumoniae–positive samples, 24 (2.4%) had mutations for macrolide-resistant M. pneumoniae (MRMp). MRMp rates are...

Полное описание

Библиографические подробности

Главные авторы:	Amy L. Leber, Tori Embry, Kathy Everhart, Jeanette Taveras, Sophonie J. Oyeniran, Huanyu Wang
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Centers for Disease Control and Prevention 2025-03-01
Серии:	Emerging Infectious Diseases
Предметы:	Mycoplasma pneumoniae COVID-19 respiratory infections severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS
Online-ссылка:	https://wwwnc.cdc.gov/eid/article/31/3/24-1570_article
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!